Quinelorane

• CAT Number: I035343
• CAS Number: 97466-90-5
• Molecular Formula: C14H22N4
• Molecular Weight: 246.36
• Purity: 98%
• Synonyms: Quinelorane
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (5aR,9aR)-6-propyl-5a,7,8,9,9a,10-hexahydro-5H-pyrido[2,3-g]quinazolin-2-amine
• InChI: InChI=1S/C14H22N4/c1-2-5-18-6-3-4-10-7-12-11(8-13(10)18)9-16-14(15)17-12/h9-10,13H,2-8H2,1H3,(H2,15,16,17)/t10-,13-/m1/s1
• InChIKey: TUFADSGTJUOBEH-ZWNOBZJWSA-N
• SMILES: CCCN1CCC[C@H]2[C@H]1CC3=CN=C(N=C3C2)N

Quinelorane（Cat No.:I035343）is a synthetic compound classified as a selective dopamine D2 receptor agonist. It has shown potential in modulating dopamine pathways, making it a subject of interest in neuroscience and pharmacology. Quinelorane’s ability to specifically activate D2 receptors makes it useful in studying disorders related to dopamine dysfunction, such as Parkinson’s disease, schizophrenia, and addiction. In preclinical studies, quinelorane has demonstrated effects on motor activity and behavior. Its potential therapeutic applications include neurodegenerative diseases and conditions involving dopaminergic imbalance, though further research is needed to assess its safety and efficacy in clinical settings.

Reference

1: Tsuchioka A, Oana F, Suzuki T, Yamauchi Y, Ijiro T, Kaidoh K, Hiratochi M. Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions. Neuroreport. 2015 Dec 16;26(18):1126-32. doi: 10.1097/WNR.0000000000000484. PubMed PMID: 26559726.
2: Ponce G, Quiñones-Lombraña A, Martín-Palanco NG, Rubio-Solsona E, Jiménez-Arriero MÁ, Palomo T, Hoenicka J. The Addiction-Related Gene Ankk1 is Oppositely Regulated by D1R- and D2R-Like Dopamine Receptors. Neurotox Res. 2016 Apr;29(3):345-50. doi: 10.1007/s12640-015-9545-9. Epub 2015 Jul 21. PubMed PMID: 26194616.
3: Chen YW, Morganstern I, Barson JR, Hoebel BG, Leibowitz SF. Differential role of D1 and D2 receptors in the perifornical lateral hypothalamus in controlling ethanol drinking and food intake: possible interaction with local orexin neurons. Alcohol Clin Exp Res. 2014 Mar;38(3):777-86. doi: 10.1111/acer.12313. Epub 2013 Nov 15. PubMed PMID: 24236888; PubMed Central PMCID: PMC4203365.
4: Salles MJ, Hervé D, Rivet JM, Longueville S, Millan MJ, Girault JA, Mannoury la Cour C. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens. J Neurochem. 2013 May;125(4):532-44. doi: 10.1111/jnc.12206. Epub 2013 Mar 11. PubMed PMID: 23410496.
5: Saul’skaia NB, Terekhova EA. [Synergetic activation of the nucleus accumbens nirtergic system by dopamine D1 and D2 receptor agonists]. Ross Fiziol Zh Im I M Sechenova. 2012 Jul;98(7):819-26. Russian. PubMed PMID: 23074829.
6: Strecker K, Adamaszek M, Ohm S, Wegner F, Beck J, Schwarz J. The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice. J Neural Transm (Vienna). 2012 Nov;119(11):1351-9. doi: 10.1007/s00702-012-0815-x. Epub 2012 May 10. PubMed PMID: 22569849.
7: Ces A, Reiss D, Walter O, Wichmann J, Prinssen EP, Kieffer BL, Ouagazzal AM. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists. Neuropsychopharmacology. 2012 Jan;37(2):378-89. doi: 10.1038/npp.2011.175. Epub 2011 Aug 31. PubMed PMID: 21881568; PubMed Central PMCID: PMC3242299.
8: Thomsen M, Ralph RJ, Caine SB. Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains. Exp Clin Psychopharmacol. 2011 Oct;19(5):342-60. doi: 10.1037/a0024053. PubMed PMID: 21843011; PubMed Central PMCID: PMC3319345.
9: Flores-Barrera E, Vizcarra-Chacón BJ, Bargas J, Tapia D, Galarraga E. Dopaminergic modulation of corticostriatal responses in medium spiny projection neurons from direct and indirect pathways. Front Syst Neurosci. 2011 Mar 29;5:15. doi: 10.3389/fnsys.2011.00015. eCollection 2011. PubMed PMID: 21483724; PubMed Central PMCID: PMC3070216.
10: Mannoury la Cour C, Salles MJ, Pasteau V, Millan MJ. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors. Mol Pharmacol. 2011 Jan;79(1):91-105. doi: 10.1124/mol.110.065409. Epub 2010 Oct 15. PubMed PMID: 20952497.
11: Wu HC, Chiu CH, Tung KC, Chen GD, Peng HY, Lin TB. Dopaminergic D2 receptors activate PKA to inhibit spinal pelvic-urethra reflex in rats. Am J Physiol Renal Physiol. 2010 Sep;299(3):F681-6. doi: 10.1152/ajprenal.00090.2010. Epub 2010 Jun 16. PubMed PMID: 20554643.
12: Moffett MC, Song J, Kuhar MJ. CART peptide inhibits locomotor activity induced by simultaneous stimulation of D1 and D2 receptors, but not by stimulation of individual dopamine receptors. Synapse. 2011 Jan;65(1):1-7. doi: 10.1002/syn.20815. PubMed PMID: 20506412; PubMed Central PMCID: PMC2939215.
13: Baskerville TA, Allard J, Wayman C, Douglas AJ. Dopamine-oxytocin interactions in penile erection. Eur J Neurosci. 2009 Dec 3;30(11):2151-64. doi: 10.1111/j.1460-9568.2009.06999.x. Epub 2009 Nov 25. PubMed PMID: 20128851.
14: Depoortère R, Bardin L, Rodrigues M, Abrial E, Aliaga M, Newman-Tancredi A. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors. Behav Pharmacol. 2009 Jul;20(4):303-11. doi: 10.1097/FBP.0b013e32832ec5aa. PubMed PMID: 19584712.
15: Bailey A, Metaxas A, Yoo JH, McGee T, Kitchen I. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose ‘binge’ cocaine administration paradigm. Eur J Neurosci. 2008 Aug;28(4):759-70. doi: 10.1111/j.1460-9568.2008.06369.x. Epub 2008 Jul 30. PubMed PMID: 18671743.
16: Qu Y, Swerdlow NR, Weber M, Stouffer D, Parsons LH. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacol Biochem Behav. 2008 Oct;90(4):686-90. doi: 10.1016/j.pbb.2008.05.012. PubMed PMID: 18579193; PubMed Central PMCID: PMC3250091.
17: Pappas SS, Behrouz B, Janis KL, Goudreau JL, Lookingland KJ. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice. Brain Res. 2008 Jun 12;1214:1-10. doi: 10.1016/j.brainres.2008.03.010. Epub 2008 Mar 19. PubMed PMID: 18462709.
18: Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, Koob GF, Tonegawa S, Zhang J, Xu M. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci. 2007 Nov 28;27(48):13140-50. PubMed PMID: 18045908; PubMed Central PMCID: PMC2747091.
19: Brooks JM, Sarter M, Bruno JP. D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex. Neuropharmacology. 2007 Sep;53(3):455-63. Epub 2007 Jun 26. PubMed PMID: 17681559; PubMed Central PMCID: PMC2000917.
20: Bruins Slot LA, Palmier C, Tardif S, Cussac D. Action of novel antipsychotics at human dopamine D3 receptors coupled to G protein and ERK1/2 activation. Neuropharmacology. 2007 Aug;53(2):232-41. Epub 2007 May 21. PubMed PMID: 17588617.